搜索优化
Rewards
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
FierceBiotech
1 天
Abbott advances clinical studies in pulsed field ablation, collects mapping clearance from FDA
Abbott has received an FDA clearance for the latest version of its sensor-laden catheter used to map out the electrical ...
FierceBiotech
1 天
Bruker spools up spatial biology division from NanoString, Canopy assets
Bruker has formed a new, single division out of the various spatial biology assets it has acquired over the years. | Bruker ...
FierceBiotech
1 天
Capricor cell therapy improves cardiac and upper limb function in phase 2 Duchenne muscular ...
Capricor Therapeutics is taking a victory lap for their phase 2 Duchenne muscular dystrophy (DMD) trial. | Capricor ...
FierceBiotech
1 天
After axing its sole clinical prospect last year, Alaunos cuts ties with Precigen
Alaunos Therapeutics is axing an agreement with Precigen, giving up licensing rights to a personalized T-cell platform. | ...
FierceBiotech
1 天
Gilead gives up on $15M MASH bet with Yuhan after mulling preclinical data
In a year that has seen an approval and a raft of readouts for metabolic dysfunction-associated steatohepatitis (MASH), ...
FierceBiotech
1 天
Chutes & Ladders—Lilly goes all-in on AI with new exec position
Eli Lilly is ramping up its efforts to incorporate AI across its business by appointing Thomas Fuchs to the new role of chief ...
FierceBiotech
2 天
Turnstone lays off 60% of staff, shakes up C-suite to keep cancer cell therapy on track
In order to focus its resources on the phase 1 program, dubbed TIDAL-01, the company has today announced a reduction in staff ...
FierceBiotech
2 天
Sanofi flunks midphase multiple sclerosis study, dealing another blow to Denali pact
Sanofi has stopped a phase 2 trial of Denali Therapeutics-partnered oditras | Sanofi has stopped a phase 2 trial of the ...
FierceBiotech
2 天
Upstream swells IPO to $255M as it prepares to join Nasdaq along with CAMP4
Upstream Bio has swollen its IPO to $255 million as the company joins CAMP4 Therapeutics this morning in becoming the latest ...
FierceBiotech
2 天
'Impossible' FDA adcomm ends in favor of Stealth’s ultra-rare disease med
Difficult. Impossible. Agonizing. Worse than voting in the national election. | Difficult. Impossible. Agonizing. Worse than ...
FierceBiotech
2 天
Deep learning AI model scans 'dark matter' of genomic data to find 70,000 never-before-seen ...
To find RNA viruses hiding in genomic “dark matter,” researchers took advantage of one thing they all have in common: the RNA polymerase enzyme.
FierceBiotech
2 天
Glooko collects $100M, plus a new CEO, to boost its diabetes platform
The digital diabetes developer Glooko has collected $100 million and a new CEO to help boost the trajectory of its data ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈